Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis - Takeaways - MDSpire

Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis

  • By

  • Michelle Sexton

  • Nicholas C Glodosky

  • Michael Cleveland

  • Carrie Cuttler

  • Euyhyun Lee

  • Gregory R Polston

  • Timothy Furnish

  • Imanuel Lerman

  • Nathaniel M Schuster

  • Mark S Wallace

  • August 21, 2025

  • 0 min

Share

  • 1

    The study analyzed associations between medical cannabis authorization and opioid milligram equivalents in chronic pain patients.

  • 2

    Average opioid milligram equivalents at the final time point were 33.4 mg/day, with a nonsignificant increase over time.

  • 3

    Patients with long-term opioid use had a significantly higher mean opioid milligram equivalent of 85.34 mg/day at the final quarter.

  • 4

    Medical cannabis authorization did not show a statistically significant decrease in opioid milligram equivalents over time.

  • 5

    Future research is needed to determine the potential opioid-sparing effects of cannabis in chronic pain management.

Original Source(s)

Related Content